Inventor · disambiguated record
Frank Lezoualc'H
Also filed as: LEZOUALC H FRANK
4 granted patents·4 pending applications·2 citations·filing 2002–2021
58Inventor score
Files withINST NAT SANTE RECH MED4INSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE1INSERM INST NAT DE LA SANE ET1INST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM)1INST NAT SANTA ET DE LA RECH M1
Top patents by PatentIndex Score
8 records- 0158US7238693B2Aryl carbamate derivatives, preparation and use thereofINST NAT SANTA ET DE LA RECH M·Filed 2002·Granted Jul 3, 2007·2 cites·8 claims
- 0248US2023226027A1Thienopyridine derivatives for use in the treatment of coronavirus infectionINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 0346US10093627B2Tetrahydroquinoline derivatives and their use as Epac inhibitorsINST NAT SANTE RECH MED·Filed 2017·Granted Oct 9, 2018·0 cites·1 claims
- 0441US9751838B2Tetrahydroquinoline derivatives and their use as Epac inhibitorsINST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM)·Filed 2013·Granted Sep 5, 2017·0 cites·13 claims
- 0540US12502382B2EPAC1 inhibitors for the treatment of idiopathic pulmonary fibrosisINST NAT SANTE RECH MED·Filed 2020·Granted Dec 23, 2025·0 cites·14 claims
- 0637US2009169540A1Use Of An Antagonist Of Epac For Treating Human Cardiac HypertrophyINSERM INST NAT DE LA SANE ET·Filed 2006·Application pending·0 cites
- 0734US2021230179A1Thieno[2,3-b]pyridine derivatives as epac inhibitors and their pharmaceutical usesINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 0829US2017079970A1Tetrahydroquinoline derivatives and their use as epac1 inhibitors for the treatment of myocardial infarction injuryINSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frank Lezoualc'H files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →